Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/20457

TDMS Study 97013-06 Pathology Tables

NTP  EXP/TEST: 97013-06                 WATER DISINFECTION MODEL (BROMODICHLOROMETHANE)                           PAGE: 1
TEST TYPE: SUBCHRON 26-WEEK                     INITIAL AND CURRENT BODY WEIGHT                                   DATE: 06/11/04
ROUTE: SKIN APPLICATION                                                                                           TIME: 08:06:41

                                                         EIS REPORT 03


       FACILITY:  Battelle Columbus Laboratory

       NTP C#:  97013F

       CONTRACT NUMBER:  NO1-ES-65406

       CAS NUMBER:  75-27-4

       ANIMAL SUPPLIER:  TACONIC FARMS

       CAGE RANGE:  ALL

       DATE RANGE: ALL

       REASONS FOR REMOVAL:    ALL

       REMOVAL DATE RANGE:     ALL

       TREATMENT GROUPS:       INCLUDE ALL

NTP  EXP/TEST: 97013-06                 WATER DISINFECTION MODEL (BROMODICHLOROMETHANE)                           PAGE: 2
TEST TYPE: SUBCHRON 26-WEEK                     INITIAL AND CURRENT BODY WEIGHT                                   DATE: 06/11/04
ROUTE: SKIN APPLICATION                                     EISRPT03                                              TIME: 08:06:41
----------------------------------------------------------------------------------------------------------------------------------
 SPECIES-STRAIN: TG.AC HEMI-MICE            SEX: FEMALE      WEEK ON DOSE: 27     FIRST DOSE: 08/19/99
----------------------------------------------------------------------------------------------------------------------------------
                     -----INITIAL-----         ------------CURRENT-------------       -----CHANGE------
TREATMENT            N   MEAN(G)    SD         N   MEAN(G)    SD    % REL CNTRL       N   MEAN(G)    SD

 0 MG/KG            15     20.1    0.9        11     28.3    2.7                     11      8.3    2.6

 64 MG/KG           15     20.0    1.0        10     28.1    3.1        99.2         10      8.2    2.5

 128     MG/KG      15     20.2    0.7        12     28.7    3.4       101.4         12      8.5    3.1

 256     MG/KG      15     20.5    0.8        10     29.5    2.8       104.2         10      9.3    2.5

 TPA                15     19.0    1.8         0      0.0    0.0                      0      0.0    0.0




----------------------------------------------------------------------------------------------------------------------------------
 SPECIES-STRAIN: TG.AC HEMI-MICE            SEX: MALE        WEEK ON DOSE: 27     FIRST DOSE: 08/19/99
----------------------------------------------------------------------------------------------------------------------------------
                     -----INITIAL-----         ------------CURRENT-------------       -----CHANGE------
TREATMENT            N   MEAN(G)    SD         N   MEAN(G)    SD    % REL CNTRL       N   MEAN(G)    SD

 0 MG/KG            15     24.0    1.3        13     35.1    4.4                     13     11.0    4.1

 64 MG/KG           15     23.9    1.2        14     34.5    3.3        98.2         14     10.4    2.7

 128     MG/KG      15     23.9    1.1        15     36.0    3.6       102.5         15     12.0    3.2

 256     MG/KG      15     24.3    0.8        13     34.4    2.9        98.0         13     10.3    2.7

 TPA                15     22.9    1.7         0      0.0    0.0                      0      0.0    0.0

                                               -----------------------------------
                                               ---------- END-OF-REPORT ----------
                                               -----------------------------------